<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Dyslipidemia</title>
    <subTitle>a clinical approach</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Myerson, Merle</namePart>
    <role>
      <roleTerm type="text">editor.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">xxu</placeTerm>
    </place>
    <dateIssued encoding="marc">2019</dateIssued>
    <edition>First edition.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xiv, 296 pages : illustrations ; 26 cm.</extent>
  </physicalDescription>
  <tableOfContents>A Historical perspective on lipids and cardiovascular disease -- Basic lipid and lipoprotein biochemistry for clinical lipidologists -- Guidelines and risk scores -- Lipid measurement -- Step-by-step diagnosis and management plan -- Lifestyle modification in the management of dyslipidemia -- Lipid medications overview: prescription and nonprescription preparations -- Statins -- Nonstatin medications: omega-3 fatty acids, fibrates, bile acid sequestrants, niacin, and cholesterol absorption inhibitors -- Hypertriglyceridemia -- Safety and tolerability of lipid-lowering medications -- Familial hypercholesterolemia: family disease -- Complex dyslipidemias -- Children and adolescents step-by-step evaluation and management plan -- Lipid management in special populations -- A. Diagnosis and management of dyslipidemia in human immunodeficiency virus -- B. Special topics for lipid management: lipid management in special populations (Women, pregnancy, menopause) -- C. Dyslipidemia in chronic kidney disease -- D. Lipid management in older patients.</tableOfContents>
  <note type="statement of responsibility">[edited by] Merle Myerson.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Lipids</topic>
    <topic>Metabolism</topic>
    <topic>Disorders</topic>
  </subject>
  <subject authority="mesh">
    <topic>Dyslipidemias</topic>
    <topic>diagnosis</topic>
  </subject>
  <subject authority="mesh">
    <topic>Dyslipidemias</topic>
    <topic>therapy</topic>
  </subject>
  <classification authority="nlm">WD101 D998 2019</classification>
  <identifier type="isbn">1496347447</identifier>
  <identifier type="isbn">9781496347442</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">TH-BaNU</recordContentSource>
    <recordCreationDate encoding="marc">180605</recordCreationDate>
    <recordChangeDate encoding="iso8601">20200224184430.0</recordChangeDate>
    <recordIdentifier source="TH-BaNU">1011682256</recordIdentifier>
  </recordInfo>
</mods>
